Cooperative Agreement 72052721FA00001

The Pan American Health Organization (PAHO) received a $2.5 million Project Grant award from the United States Agency for International Development (USAID) to provide humanitarian assistance for COVID-19 response in Peru. This funding supports the USAID Foreign Assistance for Programs Overseas program (CFDA #98.001), which aims to advance economic growth and public health in partner countries. Under this two-year award ending in September 2023, PAHO will deliver a variety of public health...

This $256,000 National Science Foundation SBIR Phase I Project Grant to Airomatix, Inc. supports the development of a portable oxygen concentrator capable of producing breathable oxygen at higher flow rates than current models. The concentrator utilizes a novel photocatalytic reaction to separate oxygen from ambient air and store it in a chemical solution. It will then release oxygen on demand through a temperature-controlled reaction. During the one-year period of performance ending March 2023,...

This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), is supporting the development of the Aerosolve Biohelmet - a personal negative pressure device to safely transport and treat patients with highly transmissible respiratory infectious diseases like COVID-19 and influenza. The $842,408 award to Inspire RX LLC will be used to refine the Biohelmet design, conduct performance testing, and deploy the...

The Department of State Bureau of Population Refugees and Migration has awarded a $3,000,000 Cooperative Agreement under the Overseas Refugee Assistance Programs for Western Hemisphere (CFDA 19.518) to Cooperative For Assistance And Relief Everywhere, Inc. (CARE) to provide critical humanitarian and protection assistance to Venezuelan and Colombian refugees and their Ecuadorian host communities. The project, titled "ESPERANZA (ECUADOR MULTI-SECTORAL PROTECTION & ENABLING RESPONSE) FOR...

This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) focuses on developing and demonstrating a high-volume manufacturing technology for microfluidic oxygenators to treat respiratory failure. The $294,063 award to Biomembretics, Inc. aims to fabricate injection-molded microfluidic oxygenators as a safer, simpler alternative to extracorporeal membrane oxygenation (ECMO) for respiratory failure patients....

The Department of State Bureau of Population Refugees and Migration (PRM) awarded a $3 million Cooperative Agreement to Cooperative For Assistance And Relief Everywhere, Inc. (CARE USA) under the Overseas Refugee Assistance Programs for Western Hemisphere (CFDA 19.518) to provide critical humanitarian and protection assistance to Venezuelan refugees and their host communities in Ecuador from September 2021 through August 2022. Under the award, CARE USA will implement the "Multisectoral...

The U.S. Agency for International Development awarded a $1 million Project Grant to the Adventist Development and Relief Agency International to respond to health needs created by COVID-19 for vulnerable communities in Peru. The grant was awarded on July 15, 2021 under the USAID Foreign Assistance for Programs Overseas program (CFDA 98.001) and runs through November 14, 2022. Under this award, Adventist Development and Relief Agency International will deliver products and services to address the...

This $5,000,000 Cooperative Agreement awarded on September 16, 2023 by the U.S. Department of State's Bureau of Population, Refugees and Migration (PRM) under the Overseas Refugee Assistance Programs for Western Hemisphere (CFDA 19.518) will support the availability of and access to timely and relevant health care services for Venezuelan migrants and other populations of concern in Colombia. The awardee, Americares Foundation, Inc., a non-profit health-focused relief and development...

The Environmental Protection Agency Region 10 awarded $157,700 under the Surveys, Studies, Research, Investigations, Demonstrations, and Special Purpose Activities Relating to the Clean Air Act program (CFDA 66.034) to the Washington Department of Ecology on July 1, 2022 for completion by February 28, 2025. The purpose of this American Rescue Plan-funded cooperative agreement is to enhance particulate matter 2.5 (PM2.5) and other National Ambient Air Quality Standards pollutant monitoring in...

The Environmental Protection Agency Region 2 awarded the Puerto Rico Commonwealth Of $247,500 under the Surveys, Studies, Research, Investigations, Demonstrations, and Special Purpose Activities Relating to the Clean Air Act program (CFDA 66.034) for the period of August 1, 2022 through July 30, 2024. The purpose of this American Rescue Plan-funded cooperative agreement is to enhance monitoring of particulate matter 2.5 or other National Ambient Air Quality Standards pollutants in communities...